Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens. - Suppr | 超能文献

Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.

作者信息

Boyns A R, Cole E N, Phillips M E, Hillier S G, Cameron E H, Griffiths K, Shahmanesh M, Feneley R C, Hartog M

出版信息

Eur J Cancer (1965). 1974 Jul;10(7):445-9. doi: 10.1016/0014-2964(74)90028-0.

DOI:10.1016/0014-2964(74)90028-0

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.

Eur J Cancer (1965). 1974 Jul;10(7):445-9. doi: 10.1016/0014-2964(74)90028-0.

2

[Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones].[接受女性激素治疗的前列腺肿瘤患者血清中的睾酮、促卵泡激素和促黄体生成素水平]

Helv Chir Acta. 1978 Jul;45(3):287-90.

3

Age-dependent effect of Freund's adjuvant on 24-hour rhythms in plasma prolactin, growth hormone, thyrotropin, insulin, follicle-stimulating hormone, luteinizing hormone and testosterone in rats.弗氏佐剂对大鼠血浆催乳素、生长激素、促甲状腺激素、胰岛素、促卵泡激素、黄体生成素和睾酮24小时节律的年龄依赖性影响。

Life Sci. 2000 Apr 7;66(20):1969-77. doi: 10.1016/s0024-3205(00)00522-1.

4

Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.吸吮以及吸吮后注射促甲状腺激素释放激素（TRH）或促黄体生成激素释放激素（LH-RH）对血浆催乳素、促甲状腺激素、生长激素和促卵泡激素的影响。

Acta Endocrinol (Copenh). 1976 Jun;82(2):246-53. doi: 10.1530/acta.0.0820246.

5

Effect of fenoldopam, a dopamine D-1 receptor agonist, on pituitary, gonadal and thyroid hormone secretion.多巴胺 D-1 受体激动剂非诺多泮对垂体、性腺及甲状腺激素分泌的影响。

Clin Endocrinol (Oxf). 1989 Mar;30(3):231-9. doi: 10.1111/j.1365-2265.1989.tb02231.x.

6

Effect of endothelin-1 in man--impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin.内皮素-1对人体的作用——对促黄体生成素、促卵泡激素、促甲状腺激素、生长激素、促肾上腺皮质激素和催乳素基础及刺激浓度的影响。

Metabolism. 1993 Jul;42(7):902-6. doi: 10.1016/0026-0495(93)90067-x.

7

Changes of pituitary hormones in brain death.脑死亡时垂体激素的变化

Acta Neurochir (Wien). 1980;52(3-4):239-48. doi: 10.1007/BF01402079.

8

Changes in plasma levels of FSH, LH and testosterone during anti-androgenic hormone therapy for patients with prostatic cancer.前列腺癌患者抗雄激素激素治疗期间血浆促卵泡生成素、促黄体生成素和睾酮水平的变化。

Tohoku J Exp Med. 1974 Oct;114(2):145-58. doi: 10.1620/tjem.114.145.

9

Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.前列腺癌患者在雌激素治疗前及治疗期间的血浆类固醇和蛋白质激素浓度。

Acta Endocrinol (Copenh). 1976 Feb;81(2):409-26. doi: 10.1530/acta.0.0810409.

10

Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.一种新型促黄体生成激素释放激素类似物（D-丝氨酸（叔丁基）6-EA10-促黄体生成激素释放激素）对男性促性腺激素和性腺类固醇分泌的影响。

Horm Res. 1976;7(1):1-10. doi: 10.1159/000178702.

引用本文的文献

1

Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification.内分泌干扰物作为危害识别依据的关键特征共识。

Nat Rev Endocrinol. 2020 Jan;16(1):45-57. doi: 10.1038/s41574-019-0273-8. Epub 2019 Nov 12.

2

Pituitary function after orchiectomy in patients with or without earlier estrogen treatment for prostatic carcinoma.

J Endocrinol Invest. 1987 Oct;10(5):479-82. doi: 10.1007/BF03348174.

3

Hormonal aspects of prostatic cancer: a review.前列腺癌的激素方面：综述

J R Soc Med. 1985 Feb;78(2):129-35. doi: 10.1177/014107688507800212.